Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Matrix Biol. 2018 May 17;75-76:114–125. doi: 10.1016/j.matbio.2018.05.003

Figure 5. βAPN treated mice show reduced ADAMTSL2 protein content.

Figure 5

A. Western blot of pooled adult mouse aorta lysate from control and βAPN treated mice using anti-LOX. B. Quantification of LOX levels from control and βAPN treated mouse aortas from western blots (n=5; each lane is a pool of 6 aortas). LOX content is significantly upregulated following βAPN treatment. C. Western blot of pooled adult mouse aorta lysate from control and βAPN treated mice using ADAMTSL2. D. Quantification of ADAMTSL2 levels from control and βAPN treated mouse aortas from western blots (n=3; each lane is a pool of 6 aortas). ADAMTSL2 protein is significantly reduced following βAPN treatment. *** indicates p<0.001. M indicates molecular weight marker.